Health Insider Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Insider Virgin Islands.

Press releases published on August 5, 2026

10 hours ago

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Indeterminate GlobeNewswire

10 hours ago

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

10 hours ago

Entrada Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs

Indeterminate GlobeNewswire

10 hours ago

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire

10 hours ago

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue

Indeterminate GlobeNewswire

10 hours ago

Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow

Indeterminate GlobeNewswire

10 hours ago

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy

Indeterminate GlobeNewswire

10 hours ago

Telix to Host R&D Day in New York City on September 22, 2026

Indeterminate GlobeNewswire

11 hours ago

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

Indeterminate GlobeNewswire

11 hours ago

Deep Origin Introduces Novel Virtual Screening Architecture; Achieves 100-fold Hit Rate Jump on Challenging Target

Indeterminate GlobeNewswire

11 hours ago

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Indeterminate GlobeNewswire

11 hours ago

CorVel Announces Revenues and Earnings

Indeterminate GlobeNewswire

12 hours ago

Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X

Indeterminate GlobeNewswire

12 hours ago

SimpliFed Marks Second Annual National Mastitis Awareness Day During National Breastfeeding Month

Indeterminate GlobeNewswire

13 hours ago

Bluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital Pharmacies

Indeterminate GlobeNewswire

15 hours ago

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

Indeterminate GlobeNewswire

16 hours ago

Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam

Indeterminate GlobeNewswire

16 hours ago

Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Indeterminate GlobeNewswire